Introduction Since the launch of bioRxiv in 2013, preprints have seen an explosion in use and adoption across the life sciences. Preprints now represent ~10% of the biomedical literature and are seeing increasing recognition across funding bodies, policy makers, academics and universities in promotion and hiring decisions. However, this adoption and recognition is not globally…
